Supply Chain Issues Cause Temporary Drug Shortages in National Prescription Drug Plan
2 reports, 2 independent
Updated Aug 12
Gone quiet
- Reports
- 2
- Developments
- 4
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The National Prescription Drug Plan stated that temporary unavailability of certain medications was occurring due to supply challenges affecting pharmaceutical wholesalers and suppliers. A notice from the Prescription Parlour Pharmacy listed several out-of-stock medications for patients on the National Prescription Drug Plan, including Humalog Vial and Metformin.
Why it matters
The shortages affect the continuity of care for patients relying on the National Prescription Drug Plan. Meanwhile, the Healthcare Distribution Association is advocating for government support to address operational challenges within the medicines wholesale sector.
How it developed
Newest first. Tap a step to see who reported it.- Generic drug shortages and supply chain failure are currently affecting the Quebec market.Sub-event
- The Department of Health and Social Care is managing critical drug supply chain issues, specifically involving the drug Ramipril.Sub-event
- FDA regulates drug shortages and systemic supply chain issues in the US.Sub-event
Drug availability is impacted by supply chain issues affecting pharmaceutical wholesalers and suppliers.1 source